Articles

Attitude and satisfaction of health care providers towards clinical pharmacy services in Ethiopia: A post-deployment survey

Clinical pharmacy service has evolved steadily over the past few decades and is contributing to the ‘patient care journey’ at all stages. The service improves safety and effectiveness of medicines, thereby avo...

Authors: Arebu Issa Bilal, Zelalem Tilahun, Gebremedhin Beedemariam, Belete Ayalneh, Bisrat Hailemeskel and Ephrem Engidawork

Challenges of medicines management in the public and private sector under Ghana’s National Health Insurance Scheme – A qualitative study

Ghana established its National Health Insurance Scheme (NHIS) in 2003 with the goal of ensuring more equitable financing of health care to improve access to health services. This qualitative study examines the...

Authors: Paul G. Ashigbie, Devine Azameti and Veronika J. Wirtz

Assessment of the nevirapine safety signal using data from the national antiretroviral dispensing database: a retrospective study

Clinical trials showed a higher risk of skin- and liver- related adverse reactions when NVP-based antiretroviral therapy (ART) was initiated in female and male patients with baseline CD4 cell counts ≥250 and ≥...

Authors: Francis Kalemeera, Assegid T. Mengistu and Johannes Gaeseb

Attitude, barriers and facilitators to practice-based research: cross-sectional survey of hospital pharmacists in Saudi Arabia

Little is known about the perceived attitude, barriers and facilitators of Saudi Pharmacists about practice based research. We aimed to measure the attitude, barriers, and facilitators of Saudi hospital pharma...

Authors: Khizra Sultana, Majed Al Jeraisy, Maha Al Ammari, Rahul Patel and Syed Tabish R. Zaidi

Governance and pharmacovigilance in Brazil: a scoping review

This scoping review investigates the relationship between governance, pharmacovigilance, and Agencia Nacional de Vigilancia Sanitaria (ANVISA) in Brazil, which has authority over Brazil's national pharmaceutic...

Authors: Kathy Moscou, Jillian C. Kohler and Anita MaGahan

Don’t sell out safety: a call to preserve risk evaluation and mitigation strategies to reduce harm to patients and the public in the U.S.

As medicines are becoming more targeted and complex in the U.S., ensuring patients’ safe use of medications with known dangerous risks is critical for public health and safety. Therefore, the Risk Evaluation a...

Authors: Stacey L. Worthy

Patient-centred innovation to ensure access to diabetes care in Cambodia: the case of MoPoTsyo

The increasing prevalence of chronic diseases puts a high burden on the health care systems of Low and Middle Income Countries which are often not adapted to provide the care needed. Peer support programmes ar...

Authors: Josefien van Olmen, Natalie Eggermont, Maurits van Pelt, Heang Hen, Jeroen de Man, François Schellevis, David H. Peters and Maryam Bigdeli

Erratum to: Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study

Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo

Engaging Nigerian community pharmacists in public health programs: assessment of their knowledge, attitude and practice in Enugu metropolis

The Nigerian health sector battles with control of infectious diseases and emerging non-communicable diseases. Number of healthcare personnel involved in public health programs need to be boosted to contain th...

Authors: Ogochukwu Offu, Maureen Anetoh, Matthew Okonta and Obinna Ekwunife

Evaluation of Ceftriaxone utilization in internal medicine wards of general hospitals in Addis Ababa, Ethiopia: a comparative retrospective study

The irrational use of reserved antimicrobials, such as ceftriaxone, is one of the global public health issues particularly to low income countries like Ethiopia, leading to high costs of treatment or therapeut...

Authors: Tariku Shimels, Arebu I Bilal and Anwar Mulugeta

Improvements for international medicine donations: a review of the World Health Organization Guidelines for Medicine Donations, 3rd edition

Some humanitarian and development organizations respond to major natural disasters and emergencies by donating medicines. Many provide medicines on a routine basis to support health systems, particularly those...

Authors: Nuria Cañigueral-Vila, Jennifer C. Chen, Lindsey Frenkel-Rorden and Richard Laing

Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study

Withdrawal of conditional regulatory approval or subsidization of new medicines when subsequent evidence does not confirm early trial results may not be well understood or accepted by the public.

Authors: Agnes Vitry, Tuan Nguyen, Vikky Entwistle and Elizabeth Roughead

Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review

Hypertension is the leading modifiable cause of mortality worldwide. Unlike many conditions where limited evidence exists for management of older individuals, multiple large, robust trials have provided a soli...

Authors: Tariq M Alhawassi, Ines Krass and Lisa G Pont

Exploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU

Authors: Andreas Siakou and Costas Athanasakis

Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines

Authors: Maarten Van Baelen

Medicines optimisation in Northern Ireland - scope and results of a challenging project

Authors: Mike Scott, Frans van Andel and Rob Brenninkmeijer

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate

Authors: Elizabeth Docteur, Joshua Cohen, Brian K Bruen, Ruth Lopert, Avi Dor and Chuck Shih

The effective and innovative cost saving of software in managing unregistered drugs

Authors: Nur Wahida Zulkifli, Noorizan Abd Aziz, Yahaya Hassan, Mohamed Azmi Hassali and Nur Liyana Zainal Bahrin

Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines

Authors: Aneta Lipińska, Maciej Pomorski, Wojciech Matusewicz and Katarzyna Jagodzińska-Kalinowska

Pharmaceutical distribution remuneration in Europe

Authors: Sabine Vogler, Lena Lepuschütz and Peter Schneider

Insurance-based risk-sharing agreements

Authors: Augustin Terlinden, Amine Aissaoui and Olivier Ethgen

Access of high technology medicines in Russia

Authors: Liudmila Bezmelnitsyna, Dmitry Meshkov and Ramil Khabriev

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment

Authors: Rossen M Kazakov and Penka I Petrova

Collaborative models for increasing efficiency of early drug assessment

Authors: Anna Nachtnebel and Claudia Wild

Value of generic medicines: an health economics study

Authors: Martin Albrecht, Ariane Höer and Anne Zimmermann

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?

Authors: Nicola Magrini, Lorenzo Moja, Bernadette Cappello, Kees De Joncheere and Gilles Forte

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir

Authors: Hedi Schelleman, Rudy Dupree, Finn B Kristensen and Wim Goettsch

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

Authors: Christine Leopold, James D Chambers and Anita K Wagner

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil

Authors: Yared Santa-Ana-Tellez, Veronika J Wirtz, Hubert GM Leufkens and Aukje K Mantel-Teeuwisse

Determining the prices of the medicines in the absence of superiority over alternative medical technology

Authors: Wojciech Matusewicz, Katarzyna Jagodzińska-Kalinowska, Aneta Lipińska and Maciej Pomorski

A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results

Authors: Roberta Joppi, Elisa Cinconze, Luca Demattè, Renato Guseo, Claudio Jommi, Cinzia Mortarino, Daniela Pase, Chiara Poggiani, Alessandro Roggeri and Daniela Roggeri

Approval, reimbursement and pricing of high-cost cancer medicines in Australia

Authors: Agnes Vitry

Policy options to deal with high-cost medicines – survey with European policy-makers

Authors: Nina Zimmermann, Sabine Vogler and Hanne Bak Pedersen

Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer

Authors: Aris Angelis and Panos Kanavos

Developing a Drug Price Reference Index in the Philippines

Authors: Manuel A Haasis, Anna M Guerrero and Marinette J Ladioray

Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework

Authors: Panos Kanavos and Aris Angelis

Retrospective financial analysis of medicines reimbursement services in community pharmacy

Authors: Elena Chitan

Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences

Authors: Zaheer-Ud-Din Babar, Abdul Ali, Christine Kim, James Mcintosh, Malaika Samuel Namdas, Erica Lourdes Rodrigues, Komal Vallabh and Anne Rew

Scottish collaboration to integrate medicine therapy between out-patient and in-patient sectors

Authors: Kenneth R Paterson

Pharmaceutical policies in Australia and New Zealand

Authors: Zaheer-Ud-Din Babar

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system

Authors: Dumebi O Mordi, Kwesi Eghan and Jim Rankin

A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?

Authors: Anna-Theresa Renner, Julia Bobek, Herwig Ostermann, Peter Schneider and Sabine Vogler

Impact of delisting OTC medicines from reimbursement list

Authors: Petra Chytilová and Robin Šebesta

Impact of discounts on medicine prices

Authors: Peter Schneider and Sabine Vogler

Priority medicines for Europe and the World: setting a public-health-based medicines development agenda

Authors: Veronika J Wirtz

Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region

Authors: Tuan A Nguyen, Sun Qiang, Haipeng Wang, Krishna Undela and Agnes Vitry

Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure

Authors: Anna Lukačišinová and Helena Skácelová

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland

Authors: Jaana E Martikainen, Timo Maljanen, Hanna Koskinen and Sabine Vogler

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs

Authors: Elizabeth Docteur and Ruth Lopert

Financial based agreements and performance based agreements: the Belgian experience

Authors: Kim Pauwels, Isabelle Huys, Eveline Bielen, Sigrid Bormans, Robin Vincken, Henna Zheng, Minne Casteels and Steven Simoens